 6. Participants must have received one prior gemcitabine based chemotherapy regimen with or without radiation therapy. Participants must be 3 weeks or more beyond completion of prior chemotherapy 30 days beyond any experimental agent and show recovery from toxicity to within the eligibility parameters of this protocol. 